Systems biology and complex neurobehavioral traits

Pharmacopsychiatry

Volumn 41, Issue SUPPL. 1, 2008, Pages

  Glegling, I ^a,b   Hartmann, A M ^a,b   Genius, J ^a,b   Benninghoff, J ^a,b   Moller H J ^b,c   Rujescu, Dan ^a,b,c  

^a Division of Molecular and Clinical Neurobiology   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Genetics Research Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ADOPTION; ARTICLE; AUTOPSY; BRAIN FUNCTION; COGNITION; DATA ANALYSIS; FAMILY STUDY; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; HERITABILITY; HUMAN; IMAGING; METABOLOMICS; NERVE CELL CULTURE; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RISK FACTOR; RODENT; SCHIZOPHRENIA; STEM CELL; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; TRANSGENIC MOUSE; TWINS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SCHIZOPHRENIA; SYSTEMS BIOLOGY;

EID: 54749103827     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081200     Document Type: Article

References (58)

1. Andreasen NC. Understanding the causes of schizophrenia (letter). N Engl J Med 1999; 340: 645-647
2. Andreasen NC. Schizophrenia: the fundamental questions. Brain Res Brain Res Rev 2000; 31: 106-112
3. Bender W, Albus M, Möller HJ, Tretter F. Towards systemic theories in biological psychiatry. Pharmacopsychiatry 2006; 39 (Suppl 1): S4-S9
4. Benninghoff J, Schmitt A, Mössner R, Lesch KP. When cells become depressed: focus on neural stem cells in novel treatment strategies against depression. J Neural Transm 2002; 109 (5-6): 947-962
5. Bertolino A, Esposito G, CallicottJH, Mattay VS, Horn JD Van, Frank JA, Berman KF, Weinberger DR. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 2000; 157 (1): 26-33
6. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, MacGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Housman DE, Kazazian HH, Antonarakis S, Pulver AE. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998; 20 (1): 70-73
7. Boks MP, Rietkerk T, Beek MH van de, Sommer IE, Koning TJ de, Kahn RS. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol 2007; 17 (9): 567-572
8. Braun I, Genius J, Grunze H, Bender A, Möller HJ, Rujescu D. Alterations of hippocampal and prefrontal GABAergic intemeurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr Res 2008; 97 (1-3): 254-263
9. Britsch S. The neuregulin-I/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol 2007; 190: 1-65
10. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000; 288 (5466): 678-682
11. Carrasquillo MM, MacCallion AS, Puffenberger EG, Kashuk CS, Nouri N, Chakravarti A. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 2002; 32 (2): 237-244
12. Chakravarti A, Little P. Nature, nurture and human disease. Nature 2003; 421: 412-414
13. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan J, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, Aurich-Costa J, Cherif D, Gimalac A, Duijn C Van, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D, Ouelette G, Realson J. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99 (21): 13675-13680
14. Cloninger CR. The discovery of susceptibility genes for mental disorders. Proc Natl Acad Sci USA 2002; 15;99 (21): 13365-13367
15. Detera-Wadleigh SD, Goldin LR, Sherrington R, Encio I, Miguel C de, Berrettini W, Gurling H, Gershon ES. Exclusion of linkage to 5q11-13 in families with schizophrenia and other psychiatric disorders. Nature 1989; 3340 (6232): 391-393
16. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, Markel P, Lee H, Harkavy Friedman J, Kaufmann C, Cloninger CR, Tsuang MT. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 1998; 10;81 (4): 290-295
17. Goo XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. lonotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 2000; 157 (7): 1141-1149
18. Gill M, Vallada H, Collier D, Sham P, Holmans P, Murray R, MacGuffin P, Nanko S, Owen M, Antonarakis S, Housman D, Kazazian H, Nestadt G, Pulver AE, Straub RE, MacLean CJ, Walsh D, Kendler KS, DeLisi L, Polymeropoulos M, Coon H, Byerley W, Lofthouse R, Gershon E, Read CM et al. A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet 1996; 16; 67 (1): 40-45
19. Goertsches R, Villoslada P, Comabella M, Montalban X, Navarro A, Concha EG de la, Arroyo R, Lopez de Munain A, Otaegui D, Palacios R, Perez-Tur J, Jonasdottir A, Benediktsson K, Fossdal R, Sawcer S, Setakis E, Compston A, Spanish MS Genetics Group. A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease. J Neuroimmunol 2003; 143 (1-2): 124-128
20. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160 (4): 636-645
21. Grunze H, Bender A, Wendhof S, Schäfer M, Rujescu D. Neurotoxicity of NMDA antagonists. A glutamatergic theory of schizophrenia based on selective impairment of local inhibitory feedback circuits. Dialogues in Clinical Neuroscience 2000; 2 (3): 287-298
22. Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, Gross WL, Epplen JT. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004; 114 (5): 468-477
23. Jonasdottir A, Thorlacius T, Fossdal R, Jonasdottir A, Bettediktsson K, Benedikz J, jonsson HH, Sainz J, Einarsdottir H, Sigurdardottir S, Kristjansdottir G, Sawcer S, Compston A, Stefansson K, Gulcher J. A whole genome association study in Icelandic multiple sclerosis patients with 4804 markers. J Neuroimmunol 2003; 143 (1-2): 88-92
24. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199-214
25. Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995; 13 (1): 9-19
26. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, Kucherlapati R, Malhotra AK. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 2007; 12 (6): 572-580
27. Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, Pulver AE, Laurent C, Kendler KS, Walsh D, Norton N, Williams NM, Schwab SG, Lerer B, Mowry BJ, Sanders AR, Antonarakis SE, Blouin JL, DeLeuze JF, Mallet J. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 2000; 67 (3): 652-663
28. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, BassettAS, Holcomb J, Kalsi G, Mac-Quillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoega T, Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003; 73 (1): 34-48
29. Lewis DA. In pursuit of the pathogenesis and pathophysiology of schizophrenia: where do we stand? (editorial). Am J Psychiatry 2002; 159: 1467-1469
30. Lin MW, Curtis D, Williams N, Arranz M, Nanko S, Collier D, MacGuffin P, Murray R, Owen M, Gill M et al. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32. Psychiatr Genet 1995; 5 (3): 117-126. Erratum in: Psychiatr Genet 1995; 1996 Spring; 6(1): 37
31. Maier W, Hofgen B, Zabel A, Rietschel M. Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes? Eur Arch Psychiatry Clin Neurosci 2005; 255 (3): 159-166
32. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A. NMDA receptor function and human cognition-the effects of ketamine in healthy volunteers. Neuropsychopharmacology 1996; 14: 301-307
33. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 1997; 17 (3): 141-150
34. MacGuffin P, Owen MJ. Molecular genetic studies of schizophrenia. Cold Spring Harbor Symposia on Quantitative Biology 1996; 61: 815-822
35. Möller HJ, Deister A. Schizophrenia. In: Möller HJ, Laux G, Kapfhammer HP (Eds). Psychiatrie und Psychotherapie. Springer: Berlin 2000; 997-1068
36. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999; 98: 427-436
37. Norton N, Williams HJ, Owen MJ. An update on the genetics of schizophrenia. Curr Opin Psychiatry 2006; 19 (2): 158-164
38. O'Tuathaigh CM, Babovic D, O'Meara G, Clifford JJ, Croke DT, Waddington JL. Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour. Neurosci Biobehav Rev 2007; 31 (1): 60-78
39. Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull 2007; 33 (4): 905-911
40. Owen MJ. Genomic approaches to schizophrenia. Clin Ther 2005; 27 (Suppl A): S2-S7
41. Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR, Kautzer CR, Lee DH, Maijoribanks C, MacDonough DP, Nguyen BT, Norris MC, Sheehan JB, Shen N, Stern D, Stokowski RP, Thomas DJ, Trulson MO, Vyas KR, Frazer KA, Fodor SP, Cox DR. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 2001; 23; 294 (5547): 1719-1723
42. Reynolds GP, Beasley CL. GABAergic neuronal subtypes in the human frontal cortex-development and deficits in schizophrenia. J Chem Neuroanat 2001; 22 (1-2): 95-100
43. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 13; 273 (5281): 1516-1517
44. Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giggling I, Genius J, MacCarley RW, Möller H-J, Grunze H. A pharmacological model for psychosis based on NMDA receptor hypofunction. Molecular, cellular, functional and behavioral abnormalities. Biological Psychiatry 2006; 59: 721-729
45. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, MacPherson JD, Gilman B, Schaffner S, Etten WJ Van, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D, International SNP Map Working Group. A map of human genome sequence variation containing 142 million single nucleotide polymorphisms. Nature 2001; 15: 409 (6822): 928-933
46. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, Burrell GJ, Rice JP, Nertney DA, Olincy A, Rozic P, Vinogradov S, Buccola NG, Mowry BJ, Freedman R, Amin F, Black DW, Silverman JM, Byerley WF, Crowe RR, Cloninger CR, Martinez M, Gejman PV. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008; 165 (4): 497-506
47. Schizophrenia linkage collaborative group. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3. 6 and 8. Am J Med Genet 1996; 22; 67 (6): 580-594
48. Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M, Lichtermann D, Ertl MA, Maier W, Wildenauer DB. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997; 2 (2): 156-160
49. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixier M, Maier W, Wildenauer DB. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum: Genet 2003; 72 (1): 185-190
50. Sherrington PD, Nacheva E, Fischer P, Rees JK, Hoyle C, Dyer M, Harper P, Knight C, Hayhoe FG. Translocation 5:21 and interstitial deletion of chromosome 7 in a case of chronic myelomonocytic leukemia. Cancer Genet Cytogenet 1988; 31 (2): 247-252
51. Stefansson H, Sigurdsson E, Steinthorsdottir V, BjornsdottirS, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71 (4): 877-892
52. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 1997; 2 (2): 148-155
53. Straub RE, MacLean CJ, Martin RB, Ma Y, Myakishev MV, Harris-Kerr C, Webb BT, O'Neill FA, Walsh D, Kendler KS. A schizophrenia locus may be located in region 10p15-p11. Am J Med Genet 1998; 10;81 (4): 296-301
54. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71 (2): 337-348
55. Tretter F, Scherer J. Schizophrenia, neurobiology and the methodology of systemic modeling. Pharmacopsychiatry 2006; 39 (Suppl 1): S26-S35
56. Weinberger DR. Genetic mechanisms of psychosis: in vivo and post-mortem genomics. Clin Ther 2005; 27 (Suppl A): S8-S15
57. Williams NM, O'Donovan MC, Owen MJ. Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? Schizophr Bull 2005; 31 (4): 800-805
58. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004; 5 (2): 89-100